Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Long-acting insulin analogs: progressing slowly].

F Holleman1, J B L Hoekstra

  • 1Academisch Medisch Centrum/Universiteit van Amsterdam, afd. Inwendige Geneeskunde, Meibergdreef 9, 1105 AZ Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde
|September 30, 2004
PubMed
Summary

New long-acting insulin analogs, insulin glargine and insulin detemir, offer improved basal insulin stability over isophane insulin. These analogs may reduce hypoglycemia risk, but cost necessitates individualized treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Systematic Review and Expert Evaluation of Perioperative SGLT2 Inhibitor-Associated Ketoacidosis Case Reports.

Acta anaesthesiologica Scandinavica·2026
Same author

From Endoscopic Inspection to Gene-Expression: A Thorough Assessment of the Duodenal Mucosa After Resurfacing-A Prospective Study.

Digestive diseases and sciences·2025
Same author

Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events.

Cardiovascular diabetology·2022
Same author

A healthcare failure mode and effect analysis to optimise the process of blood culture performance.

The Netherlands journal of medicine·2020
Same author

Cocoon vaccination for influenza in patients with a solid tumor: a retrospective study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2020
Same author

Classifying sepsis patients in the emergency department using SIRS, qSOFA or MEWS.

The Netherlands journal of medicine·2018

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Short-acting insulin analogs have gained popularity, revealing limitations of isophane insulin for stable basal insulin delivery.
  • Long-acting insulin analogs, insulin glargine and insulin detemir, were developed to address isophane insulin's deficiencies.

Discussion:

  • Insulin glargine shows efficacy in type 2 diabetes, reducing nocturnal hypoglycemia compared to isophane insulin.
  • Insulin detemir exhibits low absorption variability and may decrease nocturnal hypoglycemia in type 1 diabetes.
  • Further research is required to fully elucidate the benefits and applications of these analogs.

Key Insights:

  • Long-acting insulin analogs provide a more stable basal insulinaemia than isophane insulin.
  • Insulin glargine and detemir demonstrate potential in reducing hypoglycemic events, particularly nocturnal ones.

Related Experiment Videos

  • Individual patient assessment is crucial due to the higher cost of insulin analogs.

    • Outlook:

    • Continued research into long-acting insulin analogs is essential.
    • Personalized treatment strategies considering efficacy, safety, and cost are key.
    • These analogs represent a significant advancement in basal insulin therapy for diabetes management.